All News

Expansion projects will increase capacity to meet growing customer demand for biologics.

A fully redundant supply of digoxin API from C2 Pharma will be available via two CMO manufacturing sources at Nobilus in Poland and Laurus Labs in India.

Patient-centricity, eco-friendly and smart packaging trends marked as the biggest growth drivers and innovations in 2019.

Aptar Pharma’s Bidose liquid system is designed for local or systemic delivery of drugs.

Robinson Brothers features alongside the Prime Minister, Rt Hon Theresa May MP, and other UK organisations who wish to use The Parliamentary Review as a platform to share knowledge, insight and experience with other companies. The Parliamentary Revi...

Future plan is to extend Sterling’s international presence to meet increasing demand from customers worldwide.

Pall and Broadley-James’ combined expertise proves complementary in addressing critical customer pain points in modern bioprocessing.

Simagchem Corp.announced today its membership to the Society of Chemical Manufacturers and Affiliates, the leading international trade association representing the batch, custom and specialty chemical industry.

EFD provides advanced primary packaging and controlled drug delivery systems for animal health products worldwide.

ILC Dover, a global leader in flexible containment solutions for the pharmaceutical and biopharmaceutical industry is expanding its Irish production footprint by opening a location in Blarney, County Cork, Ireland.

Sharp has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution. Sharp’s IRT solution is used to manage patient interactions and drug supplies during clinical trials and perform a range of functions for spons...

Sharp – a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed its relocation to its $23m state-of-the-art facility in Bethlehem, PA.

Spray+Lock is our NEW Child-Resitant Spray Packaging which consists of bottles and closures. 

Gentec Pharmaceutical Group is pleased to announce the opening of its new office in Miami, Florida, in January this year.

We are excited to announce that Excite Pharma Services continues to change the industry! 

Originally a foundation at the Institut d’Investigació en Ciències de la salut Germans Trias i Pujol (IGTP), Biointaxis has been created for the investigation of rare diseases and especially of Friedrich's Ataxia.

Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

End-to-end industrial production of innovative medical technology products.

Sichuan HuaFaMei Enterprise Co.,LTD. will attend CPHI JAPAN and CPHI NORTH AMERICA. Booth No. of CPHI Japan is  1B-11.

Booth No. of CPHI Japan is  912. Warmly Welcome to visit us.

PATHWAY manages the complexity of the entire safety assessment process on behalf of the company’s pharmaceutical and biotechnology customers.

Line of Sight approach to freeze-drying enables organizations to bring pharmaceutical products safely and quickly to market.

The 2019 China Pharma New Year Forecast was successfully held in Beijing by the Healthcare Executive and China Healthcare Industry Investment Forum, supported by the China Pharmaceutical Enterprises Association on January 19.

Asymchem has become a global leader in the pharmaceutical CDMO industry. Asymchem has been committed to the development and commercial application of green pharmaceutical technologies for many years.

CPC Scientific Inc., a leading global CDMO specializing in synthetic peptide manufacturing, announced today that they will manufacture GMP-grade neoantigen peptides for investigators at UNC Lineberger Comprehesive Cancer Center (LCCC) for th...

Uniqsis appoints Sentinel Process Systems Inc  as exclusive US partner. 

In October, Purolite and Purolite Life Sciences opens one of the largest manufacturing facilities in the world for the production of agarose-based chromatographic resins. 

Huhtamaki’s Push Tab® has been selected as the Best Innovation in the Solid Dosage Packaging category in 2019 Pharmapack Awards. The annual awards recognize new innovative products that are set to shape the future of the pharmaceutical industry.

Optimally run membrane chromatography processes will provide higher productivity, smaller-scale operations and increased robustness.

Authorized generic version of Humalog will be available in US pharmacies at 50% lower list price.

Utilizing our experience of synthesizing various nucleic acid related compounds over 60 years, Yamasa can collaborate in development of new monomers used in drug development of oligonucleotides.

Seqens offers complete and fully integrated R&D services to support our customers’ projects from initial stage to commercial manufacturing in total compliance with the highest quality, safety and environmental standards.

Nightstar Therapeutics has two potentially first-in-class mid- to late-stage clinical assets as well as preclinical programs.

MINAKEM RECHERCHE has collaborated with the research group of Prof. Gwilherm Evano, from the ULB to develop a flexible approach towards N-arylated hydantoins. We are very pleased to announce that the publication has been approved in the Journal of...

Servier, an independent international pharmaceutical company, today announced the launch of InnoPreP™ – a new preparative chromatography service offered under its contract development and manufacturing business.

The availability of three new alternative switchable LED configurations provides chemists with the unique ability to optimally undertake almost any photochemistry reaction.

Systech, a global leader in supply chain security and brand protection, today announced the latest release of its cloud-based traceability and authentication solutions, which ensure that products are authentic, safe and connected throughout the supply ...

Connecting scientists, patients, and industry to advance drug development in a collaborative open market.

Executives predict Japan to be the second fastest growing mature market for solid dose drugs in 2019, and the second fastest overall country for biologicals growth.

ISO 45001 developed to improve employee safety, reduce workplace risk and create better working conditions globally.

2019 will mark Uniplast's debut at this year's edition of CPHI Worlwide in Frankfurt, where it will showcase its expertise in plastic packaging.

SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, today announced the appointment of Dr. Haris Jamil as Biologics Manager of its recently expanded biopharmaceutical testing facility in Lincolnshire, Illinois, U...

Healthcare and pharmaceutical reforms, designed to increase access to high-value medicines, driving growth.

CPC, a leading global CRO/CDMO specializing in synthetic peptide manufacturing, have announced that they will manufacture GMP-grade neoantigen peptides for investigators at UNC Lineberger Comprehesive Cancer Center (LCCC) for the purpose of individuali...

Aptar Pharma working closely with Santen Pharmaceutical to improve patient safety, achieve dosing accuracy and maintain product integrity.

With the new structure, Lonza is positioned to leverage its innovation programs and technology platforms to create new solutions at the food-pharma convergence and in microbial control.

A superior alternative filter solution for manufacturing processes using resin-bonded filter cartridges.

Newly formed PMI BioPharma Solutions announces launch of research lab and manufacturing facilities tailored to the Pharmaceutical and Biopharmaceutical industry.

PMI BioPharma Solutions announces the appointment of David Sunseri, PhD as CEO.

WuXi STA will have exclusive access to BioLingus's novel platform to stabilize and deliver sublingually drug targets including small molecules, peptides and proteins, that are currently administered to patients via injection.

Experts in deoxofluorination and Halex chemistry, Navin are able to run this specialized chemistry in bulk, using both SF4 and XtalFluor for deoxofluorination.

SKYEPHARMA, a subsidiary of the VECTURA group, has chosen its St Quentin Fallavier site, in Lyon area, to develop its pharmaceutical packaging activities, with strategic investments in two new complete lines for bottle and blister packaging, includ...

Suspensions are dispersions of solid particles in a liquid. The solids correspond to the dispersed phase and the liquids to the dispersing agent. The production of suspensions enables the conversion of sparingly soluble active substances into a liq...

Flexible dosing systems enable quick product changes in cosmetic filling Cosmetic production is undergoing a change. It is becoming increasingly important to fill small batches of various products in a short space of time. Previously, it...

Hemarina and Delpharm today announced the signature of a partnership involving the manufacture of HEMO2life®, an additive for organ transplantation solutions.

Eco-Mastermelt (Singapore) are thrilled to announce our new ISO accreditations.

We are pleased announce we are participating in CPHI North America 2019.

Skyepharma Production SAS, (“Skyepharma”) the contract development and manufacturing organization (CDMO) specialists in the development, manufacturing and packaging of classic and complex oral solid dosage forms, and Therabel, a privately-owned...

2,800 square meters expansion of a plant in Sambuca Val di Pesa (Florence) and construction of a new automated warehouse.

MedPharm and Palvella Therapeutics hope to develop the first approved treatment for PC in the US and Europe.

The 18th Annual Contracting & Outsourcing Conference & Tabletop Exhibition will be held September 26-27, 2019 at Hyatt Regency New Brunswick, NJ, located in the heart of New Jersey’s pharmaceutical industry.

The approval enables Sirio to add special sports nutrition ingredients into products and covers six functional classes for ‘protein supplementary’, ‘speed & power’, ‘endurance’, ‘energy control’, ‘energy supplementary’, and ‘post-exercise recovery’.

The CDMO invested EUR 35 million into its operations and launched a 3-year programme to provide a compliant serialisation solution for its customers.

Collaboration provides drug discovery researchers access to European distribution and local support for library of in-stock and on-demand compounds.

The compound was first synthesized and developed by Orion, who partnered it with Bayer for Phase III clinical development. Bayer holds the global marketing rights, while Orion and its subsidiary Fermion handle all the CMC and manufacturing activities f...

The advanced candidate compound undergoing the trial has demonstrated potential to target malaria parasites before they have a chance to establish the symptoms of malaria.

Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.

Partner connectivity will be an immediate and ongoing challenge beyond the deadline and several pharma companies are likely to break agreements with current suppliers through breach of contract clauses.

Local competence in application and formulation technology for sub-Saharan African personal care market.

Cablivi is the first US approval for Sanofi's new rare blood disorders franchise.

Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.

 Avoidance of plastic waste - New packaging for Alveofact®

PDA Italy Chapter has chosen the new Chief Operating Officer of PQE Group, Claudio Puglisi, as a member of the executive committee for the role of Chapter Liaison and External Relationship.

Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.

The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation.

Femimens and Femicycle are the new products in Ananta Medicare Ltd's gynecological portfolio.

Acquisition will strengthen Hitachi's presence in the second-largest cell and gene therapy market in the world.

Our recycled tubes are made from a mixture containing 75% of these recycled, food-compliant plastics.

Mylan's Wixela Inhub is the first FDA-approved therapeutically equivalent generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or COPD.

Company hopes to contribute substantially to further optimizing and accelerating the current manufacturing processes in the biopharmaceutical industry.

The partnership will focus on rings for the administration of existing approved drugs, improving drug effectiveness and patient compliance.

Increasing appetite for digitised manufacturing and using data to improve GMP manufacturing.

Santen SA and NextPharma today announce that Santen’s Tampere manufacturing facility and related operations will be acquired by NextPharma, a leading European pharmaceutical Contract Development and Manufacturing Organisation (CDMO). The acquisition is...

Medicines regulators of the UK and Russian set out key principles to support their collaboration on improving public health.

Clients will benefit from a fully comprehensive range of validated biosafety methods to support cell bank and viral vaccine manufacturing and lot release of drug product.

B2B Cosmetics will contribute their Emuage technology, which has received the “Innovation Award” at the trade show Consumer Electronics Show (CES) in Las Vegas.

New report highlights Germany, France and Switzerland as tier-one nations for ‘drug delivery innovation’, and warns the challenge will be to scale-up and approve promising prototypes.

The new Irish facility will allow the company to continue to act as a gateway to Europe for its British and North American customers.

Company's VERIFI smart monitoring hub allows production teams to manage and maintain their containment solution which, in turn, helps assure operator safety and sterility assurance related performance during pharmaceutical manufacturing processes.

The first completed bio-banks will be used to develop more cost-effective, safe and efficacious cancer treatments.

Advanced formulation techniques such as nanomilling may provide an excellent route to improved bioavailability and enhanced therapeutic effect.

Peters Krizman AG introduces a product for the treatment of extreme dry and scaly skin, in case of neurodermatitis, eczema and psoriasis and to restore the disturbed barrier function of the skin.

Fuels growth and biosimilar development in a fast-growing market.

Chrissy Bell, Global Business Leader for Inhalation and Connected Health, at 3M speaks to Innovations in Pharmaceutical Technology about how the end user's experience can be enhanced through recent drug delivery technologies and how the challenges face...

Technological breakthroughs are changing the scope of drug delivery. In particular, inhalation technology has experienced pivotal growth in recent years. By identifying new ways to accurately and efficiently deliver drugs to the lungs, the industry is ...

3M’s inventions have improved daily life for hundreds of millions of people all over the world since 1902. Silvia Perez, President and General Manager of the Drug Delivery Systems (DDS) Division of 3M, highlights some of her company’s recent innovation...

Chrissy Bell, Global Business Leader – Inhalation and Connected Health, 3M Drug Delivery Systems shares how advances in technology, digital health, and data protection could help patients better manage their drug regimens.

Flexsafe RM TX bags enable reliable process performance for optimal cell growth.

The exhibition district will see the world's largest pharma industry event.

Bliss GVS Pharma Ltd. have received the authorisation for commercialisation of Bisacodyl suppository in the US market.

Approval of generic vigabatrin tablets granted to Teva Pharmaceuticals USA.

The LyoS 2.0 control system software is fully configurable and fully validatable for regulated pharmaceutical and biotechnology applications.

New active ingredients coming from the research of BASF’s innovation platforms on epigenetics, microbiome and extraction.

Borealis and Borouge, leading providers of innovative, value-creating plastics solutions, announce the introduction of Borealis Bormed™ BJ868MO, a high flow, heterophasic polypropylene copolymer used for the production of medical and diagnostic devices...

The $4-million investment will be used to expand topical dosage formulation development services and innovative performance testing on topical and transdermal pharmaceutical products.

The automated NevoLine bioproduction system that facilitates safer, faster and closed bioprocessing in a much smaller footprint.

Asociacion Forum Auditorias has a blog in which they cover the trending topics in the industry.

The new, strategic presence will allow the company to more easily interact and engage with venture firms and start ups in the area.

The technology will enable Cell Guidance Systems to manufacture TRIFic detection assays on-demand with highly reproducible and scalable results.

Web-based platform provides broad access to the first-ever cloud laboratory to integrate automated biology and chemistry research capabilities in a closed-loop system.

Acquisition will broaden the scope of Lilly's oncology portfolio into precision medicines.

Significantly expands Phase III assets with six expected near-term product launches, representing greater than $15 billion in revenue potential.

ELRIG UK and British Pharmacological Society initiate a 2-year strategic alliance.

Proposed acquisition will expand manufacturing capacity for innovative cell and gene therapies.

The potential transaction would position BMS to further refine its portfolio to focus on transformational medicines for patients facing serious diseases.

A ‘no deal’ Brexit will change and burden how all industries that move materials and goods across borders, including the pharmaceutical and medical device sectors, do business.

The operation has not been profitable for several years; no likely prospect of it being able to deliver an acceptable return in the medium term.

Tear Film's iLux Device offers innovative, customizable treatment for Meibomian Gland Dysfunction, a leading cause of dry eye.

PrestigeBio Pharmaceuticals Co., Ltd. (PBK) has celebrated the successful completion of their first GMP facility located in Osong, South Korea at their official grand opening.

Prestige BioPharma (“Prestige”) announced today that it has reached a licensing agreement with Cipla Limited (“Cipla”) for its trastuzumab biosimilar (HD201) under which Cipla will have exclusive rights to distribute and market the drug in selected eme...